Masimo (NASDAQ:MASI) Issues FY 2025 Earnings Guidance

Masimo (NASDAQ:MASI - Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 5.300-5.600 for the period, compared to the consensus EPS estimate of 4.970. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on MASI. Wall Street Zen lowered Masimo from a "buy" rating to a "hold" rating in a report on Friday, May 30th. Needham & Company LLC reissued a "hold" rating on shares of Masimo in a research report on Thursday, April 10th. Piper Sandler restated an "overweight" rating and issued a $200.00 price objective (down from $215.00) on shares of Masimo in a research note on Wednesday, May 7th. Wells Fargo & Company dropped their target price on shares of Masimo from $205.00 to $190.00 and set an "overweight" rating on the stock in a report on Wednesday, May 7th. Finally, BTIG Research set a $193.00 target price on shares of Masimo and gave the stock a "buy" rating in a research report on Wednesday, May 7th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $191.60.

Masimo Stock Down 1.5%

Shares of MASI stock traded down $2.59 during trading on Thursday, reaching $166.71. The company's stock had a trading volume of 590,110 shares, compared to its average volume of 641,063. The business has a fifty day moving average price of $160.11 and a 200-day moving average price of $166.78. Masimo has a one year low of $101.61 and a one year high of $194.88. The company has a quick ratio of 1.62, a current ratio of 2.17 and a debt-to-equity ratio of 0.67. The company has a market cap of $9.04 billion, a price-to-earnings ratio of -18.18 and a beta of 1.19.

Masimo (NASDAQ:MASI - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The medical equipment provider reported $1.36 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.12. The company had revenue of $372.00 million for the quarter, compared to analyst estimates of $367.79 million. Masimo had a negative net margin of 25.06% and a positive return on equity of 22.56%. The company's revenue was down 24.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.77 earnings per share. Analysts anticipate that Masimo will post 4.1 earnings per share for the current year.

Insider Activity at Masimo

In other news, COO Bilal Muhsin sold 10,000 shares of Masimo stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $163.28, for a total transaction of $1,632,800.00. Following the sale, the chief operating officer now directly owns 24,172 shares of the company's stock, valued at approximately $3,946,804.16. This trade represents a 29.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 9.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. increased its stake in shares of Masimo by 38.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 280,255 shares of the medical equipment provider's stock worth $46,690,000 after purchasing an additional 78,003 shares during the last quarter. Royal Bank of Canada grew its position in Masimo by 44.5% during the first quarter. Royal Bank of Canada now owns 43,884 shares of the medical equipment provider's stock valued at $7,311,000 after acquiring an additional 13,513 shares during the last quarter. AQR Capital Management LLC lifted its stake in Masimo by 136.5% in the first quarter. AQR Capital Management LLC now owns 8,142 shares of the medical equipment provider's stock worth $1,305,000 after purchasing an additional 4,700 shares during the last quarter. Jones Financial Companies Lllp lifted its stake in shares of Masimo by 1,267.1% in the 1st quarter. Jones Financial Companies Lllp now owns 2,201 shares of the medical equipment provider's stock valued at $367,000 after acquiring an additional 2,040 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Masimo during the first quarter valued at approximately $220,000. Institutional investors and hedge funds own 85.96% of the company's stock.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.